Eduard Cabre

Summary

Publications

  1. ncbi Nutrition in alcoholic steatohepatitis: more of the same or something new?
    Eduard Cabre
    Department of Gastroenterology, Hospital Universitari Germans Trias i PujolBadalona, Catalonia, Spain
    Curr Opin Clin Nutr Metab Care 11:626-31. 2008
  2. ncbi Irritable bowel syndrome: can nutrient manipulation help?
    Eduard Cabre
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Curr Opin Clin Nutr Metab Care 13:581-7. 2010
  3. ncbi Top-down therapy: is the evidence strong enough?
    Eugeni Domenech
    Department of Gastroenterology and Hepatology, IBD Unit, Hospital Universitari Germans Trias i Pujol, ES 08916 Badalona, Spain
    Dig Dis 27:306-11. 2009
  4. ncbi Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen
    Eugeni Domenech
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    J Clin Gastroenterol 44:34-7. 2010
  5. ncbi Impact of capsule endoscopy findings in the management of Crohn's Disease
    Vicente Lorenzo-Zúñiga
    Department of Gastroenterology, Endoscopy Unit, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s n, 08916 Badalona, Spain
    Dig Dis Sci 55:411-4. 2010
  6. ncbi Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease
    Eugeni Domenech
    Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 17:971-5. 2011
  7. ncbi Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab)
    Esther Garcia-Planella
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Eur J Gastroenterol Hepatol 15:351-4. 2003
  8. ncbi Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy
    Eugeni Domenech
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 14:1373-9. 2008
  9. ncbi Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
    Yamile Zabana
    Fundació Institut d Investigació en Ciències de la Salut Germans Trias i Pujol, Catalonia, Badalona, Spain
    Inflamm Bowel Dis 14:1387-91. 2008
  10. ncbi [Portal hypertension in patients with inflammatory bowel disease]
    Carles Leal-Valdivieso
    Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Espana
    Gastroenterol Hepatol 33:297-302. 2010

Collaborators

  • Eugeni Domenech
  • Miquel A Gassull
  • J P Gisbert
  • V Lorenzo-Zúñiga
  • Julian Panes
  • Guillermo Bastida
  • X Calvet
  • Belen Beltran
  • Miriam Mañosa
  • Isabel Bernal
  • Esther Garcia-Planella
  • Yamile Zabana
  • C Loras
  • Carles Leal-Valdivieso
  • Josep Mañé
  • Mercè Navarro-Llavat
  • Ingrid Marin
  • Ana Bargalló
  • Jose Luis Cabriada
  • Marco A Alvarez
  • Victoria Gonzalo
  • M Piqueras
  • M Minguez
  • José R Sáenz
  • Jordi Prtiz
  • Juan E Naves
  • J M Viver
  • M Torres
  • Llúcia Titó Espinagosa
  • Albert Villoria
  • Antonia Montserrat
  • J Barrio
  • C Saro
  • Federico Gómez Camacho
  • A Abad
  • Ramón Atienza
  • O Merino
  • D Ginard
  • M Esteve
  • Rocio Temiño
  • Paula Gil-Simón
  • A Gutierrez
  • Marcela Perez
  • Cristina Sanchez
  • Montserrat Forné
  • Andrea Nevarez
  • Cristobal de la Coba Ortiz
  • L Vida
  • M Rodriguez-Carballeira
  • M Andreu
  • Eva Iglesias Flores
  • Jorge Carlos Espinós
  • Arantxa Iribarren
  • David Montfort
  • Jesus Barrio
  • I Ordás
  • Jaume Boadas
  • Ana Muñagorri
  • L Bujanda
  • Inez Gil
  • M Chaparro
  • Valle Garcia Sanchez
  • Maria Belen Irastorza
  • Francisco Mora
  • F Fernandez-Banares
  • Merce Rosinach
  • Mercè Barenys
  • I Pascual
  • Ana Belen Vega
  • F Gonzalez-Huix
  • Jordi Xaus
  • Violeta Lorén
  • Isabel Serra
  • Jose M Manterola
  • Jordi Sanchez-Delgado
  • Elisabet Pedrosa
  • Isabel Ojanguren
  • Cristina Saro
  • Joaquin Hinojosa
  • Daniel Ginard
  • Juan Antonio Arévalo
  • Robert Araméndiz
  • Antonio López San Román
  • Sílvia Carrión
  • Ramon Planas
  • Silvia Montoliu
  • Jaume Boix
  • Maria Esteve-Comas

Detail Information

Publications22

  1. ncbi Nutrition in alcoholic steatohepatitis: more of the same or something new?
    Eduard Cabre
    Department of Gastroenterology, Hospital Universitari Germans Trias i PujolBadalona, Catalonia, Spain
    Curr Opin Clin Nutr Metab Care 11:626-31. 2008
    ....
  2. ncbi Irritable bowel syndrome: can nutrient manipulation help?
    Eduard Cabre
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Curr Opin Clin Nutr Metab Care 13:581-7. 2010
    ..To describe the evidences for the usefulness of dietary manipulations (including the use of probiotics and prebiotics) in the management of irritable bowel syndrome (IBS)...
  3. ncbi Top-down therapy: is the evidence strong enough?
    Eugeni Domenech
    Department of Gastroenterology and Hepatology, IBD Unit, Hospital Universitari Germans Trias i Pujol, ES 08916 Badalona, Spain
    Dig Dis 27:306-11. 2009
    ..In addition, there is a risk of overtreating those 10-30% of patients that will have a benign course of the disease; that's the reason why the implementation of top-down strategies remains as a matter of debate...
  4. ncbi Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients with inflammatory bowel disease initially treated with a three-infusion induction regimen
    Eugeni Domenech
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    J Clin Gastroenterol 44:34-7. 2010
    ....
  5. ncbi Impact of capsule endoscopy findings in the management of Crohn's Disease
    Vicente Lorenzo-Zúñiga
    Department of Gastroenterology, Endoscopy Unit, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s n, 08916 Badalona, Spain
    Dig Dis Sci 55:411-4. 2010
    ..Capsule endoscopy (CE) has proven efficacy in detecting mucosal lesions of the upper gastrointestinal tract and it has been widely evaluated for assessing small-bowel lesions in patients with suspected or established Crohn's disease (CD)...
  6. ncbi Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease
    Eugeni Domenech
    Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 17:971-5. 2011
    ..The aim of this study was to evaluate the response to thiopurines in patients with steroid-dependent IBD according to their smoking habits...
  7. ncbi Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab)
    Esther Garcia-Planella
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Eur J Gastroenterol Hepatol 15:351-4. 2003
    ..No patient presented lupus-like syndrome. CONCLUSIONS: Only a few CD patients treated with infliximab and immunosuppressants develop ANAs. This condition is not associated with aDNAds and/or lupus-like syndrome in the majority of cases...
  8. ncbi Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy
    Eugeni Domenech
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 14:1373-9. 2008
    ..However, its role in steroid-refractoriness remains unknown. Our goals were to evaluate the prevalence of CMV disease in UC, the best diagnostic strategy, and the influence of disease activity and/or treatment in its development...
  9. ncbi Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
    Yamile Zabana
    Fundació Institut d Investigació en Ciències de la Salut Germans Trias i Pujol, Catalonia, Badalona, Spain
    Inflamm Bowel Dis 14:1387-91. 2008
    ..The goal was to evaluate the requirements, effectiveness, and safety profile of ChP in IBD patient candidates for anti-TNF therapy...
  10. ncbi [Portal hypertension in patients with inflammatory bowel disease]
    Carles Leal-Valdivieso
    Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Espana
    Gastroenterol Hepatol 33:297-302. 2010
    ..We present the cases of two patients with IBD who developed PH and review the most likely causes of PH in IBD, as well as preventive and therapeutic strategies...
  11. ncbi Predictors of clinical response to systemic steroids in active ulcerative colitis
    Isabel Bernal
    Gastroenterology Department Hospital Universitari Germans Trias i Pujol, 5 planta, edifici general, Ctra. del Canyet, s/n, 08916, Badalona, Spain
    Dig Dis Sci 51:1434-8. 2006
    ..In conclusion, clinical evaluation 3 days after starting systemic steroids seems to be the best tool to assess short-term prognosis...
  12. ncbi Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study
    Marco A Alvarez
    Department of Gastroenterology, University Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain
    Eur J Gastroenterol Hepatol 16:1375-80. 2004
    ..CONCLUSION: This pilot study suggests that TEN associated with a short course of steroids could be a good therapeutic strategy for severe alcoholic hepatitis. This possibility deserves investigation in a randomized controlled trial...
  13. ncbi Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
    C Loras
    Department of Gastroenterology, Hospital Mutua de Terrassa, Universitat de Barcelona, Plaça Dr Robert no 5, Terrassa, Barcelona, Catalonia, Spain
    Gut 59:1340-6. 2010
    ..There is no information about the frequency of liver dysfunction in patients with inflammatory bowel disease (IBD) treated with immunosuppressants and infected with hepatitis B (HBV) and/or C virus (HCV)...
  14. ncbi [Psoas abscess as a complication of Crohn's disease: report of three cases and literature review]
    Ingrid Marin
    Servicio de Aparato Digestivo, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Hospital Universitari Germans Trias i Pujol, Badalona, Espana
    Gastroenterol Hepatol 32:557-61. 2009
    ..We review the literature and focus on the clinical factors associated with the occurrence of these abscesses and the therapeutic approach to both this septic complication and the underlying disease...
  15. ncbi Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients
    Mercè Navarro-Llavat
    Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    Digestion 80:25-9. 2009
    ..The reported incidence of such infections among IBD patients varies between 9 and 13%, but only a few prospective studies have been conducted...
  16. ncbi Nutrition in liver disease
    Eduard Cabre
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Curr Opin Clin Nutr Metab Care 8:545-51. 2005
    ..The aim of this paper is to describe the relevant medical literature published between spring 2003 and spring 2005 in the field of malnutrition in liver disease and its management...
  17. ncbi Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice
    Josep Mañé
    Research Institute Foundation in Health Sciences Germans Trias i Pujol, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 15:1155-63. 2009
    ..We aimed to evaluate the effects of Lactobacillus fermentum CECT 5716 on gut injury when administered either before or after trinitrobencene sulfonic acid (TNBS) colitis in Balb/c mice...
  18. ncbi Medication-taking behavior in a cohort of patients with inflammatory bowel disease
    Isabel Bernal
    Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, 5a planta, edifici general, Ctra. del Canyet, s/n, 08916, Badalona, Catalonia, Spain
    Dig Dis Sci 51:2165-9. 2006
    ..02). Twenty percent of patients admitted to self-medicating. An important proportion of patients with IBD admit to forget some doses of the prescribed medication in the setting of a specialized unit of a referral centre...
  19. ncbi [Infectious mononucleosis in patients with inflammatory bowel disease under treatment with azathioprine]
    Ana Bargalló
    Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Espana
    Gastroenterol Hepatol 31:289-92. 2008
    ..We report two cases of atypical infectious mononucleosis in patients with inflammatory bowel disease under azathioprine therapy and review the available evidence on the most appropriate therapeutic approach in this subset of patients...
  20. ncbi Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice
    Eugeni Domenech
    Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s n, Badalona, Catalonia, Spain
    J Clin Gastroenterol 42:395-9. 2008
    ..To assess the efficacy and safety profile of methotrexate (MTX) for the treatment of Crohn's disease (CD) in clinical practice...
  21. ncbi Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study
    Eugeni Domenech
    Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
    Inflamm Bowel Dis 14:508-13. 2008
    ....